The Indo-MIM IPO is a closed mainboard Bookbuilding offer (Fresh capital cum OFS) that opened on 23 July 2026. The Indo-MIM IPO closed on 27 July 2026, with an issue price of ₹485 per share. The Indo-MIM IPO has a face value of ₹1 and a lot size of 30 shares. The Indo-MIM IPO is listed on 30 July 2026. The Indo-MIM IPO allotment was scheduled for 28 July 2026.
On the financial front, the Indo-MIM IPO reported revenue of ₹4,321 crore for 31 Mar 2026, compared with ₹3,374 crore for 31 Mar 2025. The Indo-MIM IPO PAT was ₹534 crore against ₹424 crore. The Indo-MIM IPO EBITDA stood at ₹1,071 crore with a 25.54% margin. The Indo-MIM IPO net worth as of 31 Mar 2026 was ₹2,820 crore.
Always verify The Indo-MIM IPO details and GMP data with the official offer document before investing in the Indo-MIM IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
4,897
4,141
3,758
Revenue
4,321
3,374
2,900
PAT
534
424
284
EBITDA
1,071
933
743
Net Worth
2,820
2,199
2,051
Reserves
2,573
2,031
1,889
Total Borrowing
1,090
1,247
1,085
Indo-MIM IPO Financials FAQs
Revenue of Indo-MIM (Amount in ₹ Crore) — 31 Mar 2026: 4,321; 31 Mar 2025: 3,374; 31 Mar 2024: 2,900. Profit after tax (PAT) — 31 Mar 2026: 534; 31 Mar 2025: 424; 31 Mar 2024: 284.
EBITDA of Indo-MIM (Amount in ₹ Crore) — 31 Mar 2026: 1,071; 31 Mar 2025: 933; 31 Mar 2024: 743. The EBITDA margin is 25.54%.
Total assets — 31 Mar 2026: 4,897; 31 Mar 2025: 4,141; 31 Mar 2024: 3,758. Net worth — 31 Mar 2026: 2,820; 31 Mar 2025: 2,199; 31 Mar 2024: 2,051. Reserves & surplus — 31 Mar 2026: 2,573; 31 Mar 2025: 2,031; 31 Mar 2024: 1,889. (Amount in ₹ Crore)
Total borrowing of Indo-MIM (Amount in ₹ Crore) — 31 Mar 2026: 1,090; 31 Mar 2025: 1,247; 31 Mar 2024: 1,085. Debt-to-equity ratio: 0.39.
The financials shown for Indo-MIM IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
